Neurology

CGTLive’s Weekly Rewind – May 27, 2022

Review top news and interview highlights from the week ending May 27, 2022.

Developing Safer Viral Vectors for Gene Therapy

The chief executive officer of Ring Therapeutics, Tuyen Ong, MD, discussed the potential of anellovirus vectors for use in gene therapy.

Amy Pooler, PhD, on Improving Gene Delivery to the CNS

The vice president of neuroscience at Sangamo Therapeutics discussed identifying novel capsids with improved neuronal transduction to the CNS.